Social Determinants of Health Associated With Healthcare Resource Utilization in Hereditary Angioedema
Recommended Citation
Baptist A, Meadows JA, Riedl M, Davis T, Robinson S, Huang Y, Mohammadi I, Sing K, Fox D, Schultz B, Juethner S. Social Determinants of Health Associated With Healthcare Resource Utilization in Hereditary Angioedema. J Allergy Clin Immunol 2026; 157(2):AB75.
Document Type
Conference Proceeding
Publication Date
2-10-2026
Publication Title
J Allergy Clin Immunol
Keywords
dipeptidyl carboxypeptidase inhibitor, angioneurotic edema, Caucasian, child, complement system, conference abstract, congenital disorder, controlled study, diagnosis, drug therapy, emergency department visit, ethnicity, familial disease, female, highest income group, Hispanic, hospitalization, human, lowest income group, major clinical study, male, patient care, prescription, social determinants of health, suburban area, United States
Abstract
Rationale: Hereditary angioedema (HAE) is a rare inherited disorder characterized by unpredictable swelling attacks. Patient care can be impacted by social determinants of health. Methods: US patients from Inovalon’s closed claims database with ≥2 medical claims (D84.1 complement system or T783XXX angioedema) and ≥1 prescription for HAE medication were screened between 1/1/2017–9/30/2021 (first claim as index date). Eligible patients had 12 months’ continuous enrollment in a health plan pre- and 24 months post-index without a pre-index documented history of HAE or evidence of angiotensin-converting enzyme inhibitor use after diagnosis. Race/ethnicity, income, and rurality were analyzed to understand differences in healthcare resource utilization (HCRU). Results: In multivariable models adjusting for age and sex, Black and Hispanic patients had a 133% and 71% higher rate of HAE-related emergency department (ED) visits than White patients (rate ratio [RR; 95% CI]: 2.33 [1.74–3.13] and 1.71 [1.16–2.50], respectively), while Black patients also had a greater rate of HAE-related hospitalizations vs White patients (RR [95% CI]: 2.25 [1.10–4.57]). Low-income (<$50K) patients had a 78% higher rate of HAE-related ED visits than high-income (≥$50K) patients (RR [95% CI]: 1.78 [1.37–2.31]) with no differences in hospitalizations (RR [95% CI]: 0.93 [0.49–1.78]). There were no significant differences in HAE-related HCRU between patients who lived in rural vs urban/suburban environments. Conclusions: This study suggests disparities in healthcare outcomes exist based on race/ethnicity and income among patients making their first claim for HAE. Additional patient-centric research within HAE communities is needed to improve health equity.
Volume
157
Issue
2
First Page
AB75
